Clinical Trial Update: ESCAPE Mechanistic Substudies - Ancillary to ESCAPE

View source ↗

Summary

The ESCAPE mechanistic substudies, ancillary to the ESCAPE trial, have completed its mechanistic investigations under NHLBI oversight.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Failure

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED